Markets

Sorrento Therapeutics (SRNE) Soars: Stock Up 8.6% - Tale of the Tape

Sorrento Therapeutics, Inc. ( SRNE ) was a big mover last session, as its shares rose nearly 9% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Feb 21, as the stock is now up almost 56%.

In the last 30 days, the company has not seen any estimate revision and the Zacks Consensus Estimate also remained unchanged. However, yesterday's price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Sorrento Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked medical stocks include Covidien plc ( COV ), NuVasive, Inc. ( NUVA ) and Stryker Corporation ( SYK ). All three carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

COVIDIEN PLC (COV): Free Stock Analysis Report

NUVASIVE INC (NUVA): Free Stock Analysis Report

SORRENTO THERAP (SRNE): Get Free Report

STRYKER CORP (SYK): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NUVA SRNE SYK

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More